GLP-1 Receptor Agonists and Cognitive Health
GLP-1 receptor agonist cognitive outcomes are increasingly relevant in diabetes care. These agents improve survival but may extend the period for dementia risk. Understanding sex-specific effects is crucial for patient counseling.
Large Study Finds No Evidence Cannabis Use Accelerates Cognitive Decline or Raises Dementia Risk in Older Adults
This study on cannabis cognitive decline dementia risk older adults found no significant association between cannabis use and accelerated cognitive decline or increased dementia risk. The research analyzed large population cohorts and used Mendelian…
2025 Study Shows No Link Between Cannabis Use and Cognitive Decline in Older Adults
The cannabis cognitive aging study 2025 found no evidence that cannabis use accelerates cognitive decline or dementia risk in older adults. This large observational study combined data from two major cohorts and Mendelian randomisation analyses. The…
Cannabis use, cognitive function and dementia risk in older adults: observational and genetic analyses.
This study examines cannabis use disorder dementia risk and cognitive function in older adults. Observational and genetic analyses reveal no significant increase in dementia risk. These findings provide important insights for clinicians and patients…